This report was recently updated on April 17 2024 with the latest and most recent
market numbers
Global mRNA Manufacturing Market Size, Trends & Analysis - Forecasts to 2028 By Application (Vaccine Development [Infectious Disease, Cancer, Other Indications], Therapeutics Development & Other Applications), By Scale (Pre-commercial/R&D Scale Manufacturing, Commercial Scale Manufacturing), By End-Use (CMOs/CDMOs/CROs, Pharmaceutical & Biotechnology Company, Academic & Government Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis
The global mRNA manufacturing market size is projected to grow at a CAGR of 8.3% from 2023 to 2028.
mRNA is a versatile platform for the development of therapeutic as well as prophylactic vaccines against chronic and infectious diseases. In terms of efficacy, immunogenicity, and manufacturing cost, mRNA-derived products outperform conventional medicines. Over the forecast period, the mRNA synthesis and manufacturing services market is expected to grow due to continuous innovations and improvements in mRNA manufacturing services.
Growing demand for gene therapies, an increase in chronic and infectious diseases, and an increase in clinical trials for cancer therapies and infectious diseases are all expected to propel the mRNA manufacturing market forward at a rapid pace in the coming years.
Furthermore, advanced medical technologies, increased customization, improved quality and efficacy services, and novel pharmaceutical innovations boost market growth. On the other hand, a lack of flexible, sustainable, and cost-effective manufacturing processes is impeding the growth of mRNA synthesis and manufacturing services.
Following the onset of the COVID-19 pandemic, mRNA therapeutics and mRNA vaccines have received significant attention as a revolutionary novel drug class for the treatment of COVID-19, as well as a variety of other diseases such as oncological disorders, infectious diseases, and genetic disorders. Many mRNA therapeutics / mRNA vaccines are currently being developed or commercialized for a wide range of indications. As a result, the demand for mRNA manufacturing capacity is clearly increasing.
Pfizer Inc. and BioNTech SE, for example, announced in November 2020 that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 had demonstrated efficacy against COVID-19 in participants with no prior evidence of SARS-CoV-2 infection.
The pharmaceutical & biotechnology companies’ segment is expected to witness the largest share in the global mRNA Manufacturing Market during the forecast period of 2023-2028. Pharmaceutical companies do complex testing daily for chronic diseases and develop various drugs for several diseases. With diseases increasing and with more awareness for research of cures and drugs, the pharmaceutical & biotechnology companies’ segment is expected to witness the largest share.
The academic & government research institutes segment is expected to grow the fastest during 2023-2028. Research institutes conduct clinical research that bridges the current gaps and identifies treatment plans for existing stem cell projects. This increased awareness in research, additional funding, and government initiatives save time and cost of production with efficiency and consistency.
The vaccine development segment is expected to witness the largest share in the global mRNA manufacturing market during the forecast period of 2023-2028. Unlike DNA, mRNA only needs to reach the cytosol before being transcribed into the antigen by the cell machinery. Any desired sequence can thus be designed, manufactured in vitro, and delivered to any type of cell.
The development and production of mRNA vaccines is relatively simple, scalable, and extremely fast. When producing mRNA in vitro via an enzymatic process, there is no need to remove cells or host cell proteins. This streamlined manufacturing process allows facilities to quickly switch to a new protein target with minimal process and formulation adaptation. As a result, the vaccine development segment is expected to have the highest share.
The therapeutics development segment is expected to grow the fastest during 2023-2028. mRNA can be engineered to transiently express proteins by structurally resembling natural mRNA. Advances in addressing the inherent challenges of this drug class, particularly in controlling the translational efficacy and immunogenicity of the mRNA, pave the way for a broad range of potential applications. Clinical trials for cancer immunotherapies and infectious disease vaccines based on mRNA have begun.
Many companies are focusing on drug development thoroughly post-pandemic and this will further enhance the segment during the forecast period. Because of their numerous advantages, including shorter development timelines, higher biological efficiency, and versatile delivery platforms with lower toxicity levels, mRNA therapeutics have emerged as a promising alternative to conventional treatment approaches.
The pre-scale/R&D manufacturing segment is expected to witness the largest share in the global mRNA manufacturing market during the forecast period of 2023-2028. Due to an increase in diseases, there is substantial growth in the process of research and development. Companies are focusing more on research and development in order to implement smooth and advanced technologies. As a result, the pre-scale manufacturing segment is expected to account for most of the market during the forecast period.
The commercial manufacturing segment is expected to grow the fastest during 2023-2028. The manufacturing pipeline is scaled up to produce commercial-scale batches of the drug once a viable active pharmaceutical ingredient (API) has been developed and clinical trials have yielded promising results. When dealing with larger quantities, for example, equipment that works perfectly for small batches may not run as quickly or efficiently. The physical and mechanical parameters of the finished product may vary in large quantities. All these difficulties are avoidable with careful planning and commercial manufacturing.
The North America segment is expected to witness the largest share in the global mRNA manufacturing market during the forecast period of 2023-2028. Due to an increase in research in the healthcare segment, the North America segment will dominate the global mRNA manufacturing market. Significant research funding, expanded federal programs aimed at RNA-based medicines, and an increase in the number of clinical trials will drive the market in North America. For example, in November 2020, the National Institutes of Health (NIH), the Defence Department, and federally funded academic laboratories all supported Graham and others' basic research, which was critical in the rapid development of COVID-19 vaccines.
An increase in the standard of living, and new technologies in the medical sector are a few reasons which drive the market in the United States. As one of the most developed nations in the world, the United States is a hub for complex medical treatments for many people around the world. The mRNA manufacturing market industry in the United States has been substantially strong for a few years due to the increasing demand for consumers in the healthcare domain, and it is estimated to grow further during the forecast period.
Asia-Pacific is expected to grow the fastest during 2023-2028. The Asia-Pacific region has been developing huge infrastructure for the healthcare sector and many medical advancements via research.
There is also a substantial growth due to investments in research and development especially in stem cell research due to the increase in chronic diseases. This competitive landscape helps in the growth rate of the global mRNA manufacturing market. Furthermore, renowned companies are expanding their business in Europe for treatments and research therapies.
CureVac, Moderna, Pfizer, Translate Bio, AstraZeneca, Silence Therapeutics, Tiba Biotechnology, Thermo Fisher Scientific, Anima Biotech, and Ionis Pharmaceuticals Inc. among others, are some of the key players in the mRNA manufacturing market.
Please note: This is not an exhaustive list of companies profiled in the report.
The global mRNA manufacturing market has observed several strategic alliances between company profiles to launch new products with added functionalities and maintain revenue share & profitability. Organic and inorganic growth strategies adopted by small players have been the highlight of this market.
Chapter 1 Research Methodology
1.1 Research Assumptions
1.2 Research Methodology
1.2.1 Estimates and Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GME’s Internal Database
1.3.3 Primary Research
1.3.4 Secondary Sources & Third-Party Perspectives
1.3.4.1 Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filing, Company Blogs & Website
1.3.4.2 Secondary Data Sources: World Health Organization
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market End-User & Data Visualization
1.6 Data Validation & Publishing
1.7 Market Model
1.7.1 Model Details
1.7.1.1 Top-Down Approach
1.7.1.2 Bottom-Up Approach
1.8 Market Segmentation & Scope
1.9 Market Definition
Chapter 2 Executive Summary
2.1. Global Market Outlook
2.2 Application Outlook
2.3 Scale Outlook
2.4 End-User Outlook
2.5 Regional Outlook
Chapter 3 Global MRNA Manufacturing Market Trend Analysis
3.1. Market Introduction
3.2 Penetration & Growth Prospect Mapping
3.3 Impact of COVID-19 on the MRNA Manufacturing Market
3.4 Metric Data on Healthcare Industry
3.5 Market Dynamic
3.5.1 Market Driver Analysis
3.5.2 Market Restraint Analysis
3.5.3 Industry Challenges
3.5.4 Industry Opportunities
3.6 Porter’s Five Analysis
3.6.1 Threat of New Entrants
3.6.2 Threat of New Substitutes
3.6.3 Bargaining Power of Buyers/Suppliers
3.6.4 Intensity of Competitive Rivalry
3.7 Market Entry Strategies
Chapter 4 MRNA Manufacturing Market: Application Trend Analysis
4.1 Application: Historic Data vs. Forecast Data Analysis, 2021 vs. 2028
4.2 Vaccine Development
4.2.1 Market Estimates & Forecast Analysis of Vaccine Development Segment, By Region, 2019-2028 (USD Billion)
4.2.1 Infectious Diseases
4.2.1.1 Market Estimates & Forecast Analysis of Infectious Diseases Segment, By Region, 2019-2028 (USD Billion)
4.2.2 Cancer
4.2.2.1 Market Estimates & Forecast Analysis of Cancer Segment, By Region, 2019-2028 (USD Billion)
4.2.3 Other Indications
4.2.3.1 Market Estimates & Forecast Analysis of Other Indications Segment, By Region, 2019-2028 (USD Billion)
4.3 Therapeutics Development & Other Applications
4.3.1 Market Estimates & Forecast Analysis of Therapeutics Development & Other Applications Markets Segment, By Region, 2019-2028 (USD Billion)
Chapter 5 MRNA Manufacturing Market: Scale Trend Analysis
5.1 Scale: Historic Data vs. Forecast Data Analysis, 2021 vs. 2028
5.2 Pre-commercial/R&D Scale Manufacturing
6.2.1 Market Estimates & Forecast Analysis of Pre-commercial/R&D Scale Manufacturing Segment, By Region, 2019-2028 (USD Billion)
5.3 Commercial Scale Manufacturing
6.3.1 Market Estimates & Forecast Analysis of Commercial Scale Manufacturing Segment, By Region, 2019-2028 (USD Billion)
Chapter 6 MRNA Manufacturing Market: End-User Trend Analysis
6.1 End-User: Historic Data vs. Forecast Data Analysis, 2021 vs. 2028
6.2 CMOs/CDMOs/CROs
6.2.1 Market Estimates & Forecast Analysis of CMOs/CDMOs/CROs Segment, By Region, 2019-2028 (USD Billion)
6.3 Pharmaceutical & Biotechnology Company
6.3.1 Market Estimates & Forecast Analysis of Governance, Pharmaceutical & Biotechnology Company Segment, By Region, 2019-2028 (USD Billion)
6.4 Academic & Government Research Institutes
6.4.1 Market Estimates & Forecast Analysis of Academic & Government Research Institutes Segment, By Region, 2019-2028 (USD Billion)
Chapter 7 MRNA Manufacturing Market, By Region
7.1 Regional Outlook
7.2 North America
7.2.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)
7.2.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
7.2.3 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
7.2.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
7.2.5 U.S.
7.2.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
7.2.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
7.2.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
7.2.6 Canada
7.2.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
7.2.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
7.2.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
7.2.7 Mexico
7.2.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)
7.2.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028 (USD Billion)
7.2.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)
8.3 Europe
8.3.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)
8.3.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.3 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.5 Germany
8.3.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.6 UK
8.3.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.7 France
8.3.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.8 Russia
8.3.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.9 Italy
8.3.9.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.9.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.9.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.10 Spain
8.3.10.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.3.10.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.3.10.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.3.11 Rest of Europe
8.3.11.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)
8.3.11.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028 (USD Billion)
8.3.11.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)
8.4 Asia Pacific
8.4.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)
8.4.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.3 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.5 China
8.4.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.6 India
8.4.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.8 Japan
8.4.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.8 Australia
8.4.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.9 South Korea
8.4.9.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.4.9.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.4.9.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.4.10 Rest of Asia Pacific
8.4.10.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)
8.4.10.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028 (USD Billion)
8.4.10.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)
8.5 Central & South America
8.5.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)
8.5.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.5.3 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.5.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.5.5 Brazil
8.5.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.5.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.5.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.5.6 Rest of Central & South America
8.5.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.5.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.5.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.6 Middle East & Africa
8.6.1 Market Estimates & Forecast Analysis, By Country 2019-2028(USD Billion)
8.6.2 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.6.3 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.6.4 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.6.5 Saudi Arabia
8.6.5.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.6.5.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.6.5.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.6.6 United Arab Emirates
8.6.6.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.6.6.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.6.6.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.6.7 South Africa
8.6.7.1 Market Estimates & Forecast Analysis, By Application, 2019-2028(USD Billion)
8.6.7.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028(USD Billion)
8.6.7.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028(USD Billion)
8.6.8 Rest of Middle East & Africa
8.6.8.1 Market Estimates & Forecast Analysis, By Application, 2019-2028 (USD Billion)
8.6.8.2 Market Estimates & Forecast Analysis, By Scale, 2019-2028 (USD Billion)
8.6.8.3 Market Estimates & Forecast Analysis, By End-User, 2019-2028 (USD Billion)
Chapter 9 Competitive Analysis
9.1 Key Global Players, Recent Developments & their Impact on the Industry
9.2 Four Quadrant Competitor Positioning Matrix
9.2.1 Key Innovators
9.2.2 Market Leaders
9.2.3 Emerging Players
9.2.4 Market Challengers
9.3 Vendor Landscape Analysis
9.4 End-User Landscape Analysis
9.5 Company Market Share Analysis, 2022
Chapter 10 Company Profile Analysis
10.1 Competitive Analysis, 2022
10.2 CureVac
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Strategic Positioning
10.2.4 Info Graphic Analysis
10.3 Moderna
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Strategic Positioning
10.3.4 Info Graphic Analysis
10.4 Pfizer
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Strategic Positioning
10.4.4 Info Graphic Analysis
10.5 Translate Bio
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Strategic Positioning
10.5.4 Info Graphic Analysis
10.6 AstraZeneca
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Strategic Positioning
10.6.4 Info Graphic Analysis
10.7 Silence Therapeutics
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Strategic Positioning
10.7.4 Info Graphic Analysis
10.8 Tiba Biotechnology
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Strategic Positioning
10.8.4 Info Graphic Analysis
10.9 Thermo Fisher Scientific
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Strategic Positioning
10.9.4 Info Graphic Analysis
10.10 Other Players
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Strategic Positioning
10.10.4 Info Graphic Analysis
List of Tables
1 Technological Advancements In MRNA Manufacturing Market
2 Global MRNA Manufacturing Market: Key Market Drivers
3 Global MRNA Manufacturing Market: Key Market Challenges
4 Global MRNA Manufacturing Market: Key Market Opportunities
5 Global MRNA Manufacturing Market: Key Market Restraints
6 Global MRNA Manufacturing Market Estimates & Forecast Analysis, 2019-2028 (USD Billion)
7 Global MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
8 Therapeutics Development & Other Applications: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
9 Vaccine Development: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
10 Global MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
11 Pre-commercial/R&D Scale Manufacturing: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
12 Commercial Scale Manufacturing: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
13 Global MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
14 CMOs/CDMOs/CROs: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
15 Pharmaceutical & Biotechnology Company: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
16 Academic & Government Research Institutes: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
17 Regional Analysis: Global MRNA Manufacturing Market, By Region, 2019-2028 (USD Billion)
18 North America: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
19 North America: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
20 North America: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
21 North America: MRNA Manufacturing Market, By Country, 2019-2028 (USD Billion)
22 U.S: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
23 U.S: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
24 U.S: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
25 Canada: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
26 Canada: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
27 Canada: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
28 Mexico: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
29 Mexico: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
30 Mexico: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
31 Europe: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
32 Europe: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
33 Europe: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
34 Germany: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
35 Germany: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
36 Germany: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
37 UK: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
38 UK: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
39 UK: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
40 France: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
41 France: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
42 France: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
43 Italy: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
44 Italy: MRNA Manufacturing Market, By T Scale Type, 2019-2028 (USD Billion)
45 Italy: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
46 Spain: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
47 Spain: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
48 Spain: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
49 Rest Of Europe: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
50 Rest Of Europe: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
51 Rest of Europe: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
52 Asia Pacific: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
53 Asia Pacific: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
54 Asia Pacific: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
55 Asia Pacific: MRNA Manufacturing Market, By Country, 2019-2028 (USD Billion)
56 China: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
57 China: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
58 China: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
59 India: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
60 India: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
61 India: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
62 Japan: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
63 Japan: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
64 Japan: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
65 South Korea: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
66 South Korea: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
67 South Korea: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
68 Middle East & Africa: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
69 Middle East & Africa: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
70 Middle East & Africa: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
71 Middle East & Africa: MRNA Manufacturing Market, By Country, 2019-2028 (USD Billion)
72 Saudi Arabia: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
73 Saudi Arabia: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
74 Saudi Arabia: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
75 UAE: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
76 UAE: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
77 UAE: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
78 Central & South America: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
79 Central & South America: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
80 Central & South America: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
81 Central & South America: MRNA Manufacturing Market, By Country, 2019-2028 (USD Billion)
82 Brazil: MRNA Manufacturing Market, By Application, 2019-2028 (USD Billion)
83 Brazil: MRNA Manufacturing Market, By Scale, 2019-2028 (USD Billion)
84 Brazil: MRNA Manufacturing Market, By End-User, 2019-2028 (USD Billion)
85 CureVac: Products Offered
86 Moderna: Products Offered
87 Pfizer: Products Offered
88 Translate Bio: Products Offered
89 AstraZeneca: Products Offered
90 Silence Therapeutics: Products Offered
91 Tiba Biotechnology Inc: Products Offered
92 Thermo Fisher Scientific: Products Offered
93 Other Companies: Products Offered
List of Figures
1. Global MRNA Manufacturing Market Segmentation & Research Scope
2. Primary Research Partners and Local Informers
3. Primary Research Process
4. Primary Research Approaches
5. Primary Research Responses
6. Global MRNA Manufacturing Market: Penetration & Growth Prospect Mapping
7. Global MRNA Manufacturing Market: Value Chain Analysis
8. Global MRNA Manufacturing Market Drivers
9. Global MRNA Manufacturing Market Restraints
10. Global MRNA Manufacturing Market Opportunities
11. Global MRNA Manufacturing Market Challenges
12. Key MRNA Manufacturing Market Manufacturer Analysis
13. Global MRNA Manufacturing Market: Porter’s Five Forces Analysis
14. PESTLE Analysis & Impact Analysis
15. CureVac: Company Snapshot
16. CureVac: SWOT Analysis
17. Moderna: Company Snapshot
18. Moderna: SWOT Analysis
19. Pfizer: Company Snapshot
20. Pfizer: SWOT Analysis
21. Translate Bio: Company Snapshot
22. Translate Bio: SWOT Analysis
23. AstraZeneca: Company Snapshot
24. AstraZeneca: SWOT Analysis
25. Silence Therapeutics: Company Snapshot
26. Silence Therapeutics: SWOT Analysis
27. Tiba Biotechnology Inc: Company Snapshot
28. Tiba Biotechnology Inc: SWOT Analysis
29. Thermo Fisher Scientific: Company Snapshot
30. Thermo Fisher Scientific: SWOT Analysis
31. Other Companies: Company Snapshot
32. Other Companies: SWOT Analysis
The Global mRNA Manufacturing Market has been studied from the year 2019 till 2028. However, the CAGR provided in the report is from the year 2023 to 2028. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the mRNA Manufacturing Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
![Global mRNA Manufacturing Market Size, Trends & Analysis - Forecasts to 2028 By Application (Vaccine Development [Infectious Disease, Cancer, Other Indications], Therapeutics Development & Other Applications), By Scale (Pre-commercial/R&D Scale Manufacturing, Commercial Scale Manufacturing), By End-Use (CMOs/CDMOs/CROs, Pharmaceutical & Biotechnology Company, Academic & Government Research Institutes), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis](https://www.globalmarketestimates.com/images/cat/Healthcare.png)
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
Or view our licence options:
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
